100 Questions & Answers About Mesothelioma - Harvey I. Pass, Mary Hesdorffer, Joseph W. Belluck, Sarah Lake

100 Questions & Answers About Mesothelioma

Buch | Softcover
200 Seiten
2022 | 4th edition
Jones and Bartlett Publishers, Inc (Verlag)
978-1-284-24779-4 (ISBN)
29,95 inkl. MwSt
ADVOCATE FOR YOUR CAREAccording to the American Cancer Society, roughly 3,000 new cases of mesothelioma is diagnosed in the United States each year. No one with this cancer needs to be alone in their fight against this disease. That's where this book and the information within can help.100 Questions & Answers About Mesothelioma, Fourth Edition offers authoritative and practical answers to the most common questions asked by patients and their loved ones. What is malignant mesothelioma? What causes mesothelioma and how is it treated?Updated to include new immunotherapy treatments, 100 Questions & Answers About Mesothelioma, Fourth Edition is the only book to provide the doctor’s and patient’s views. This patient education resource gives readers authoritative, practical answers to questions about treatment options, post-treatment quality of life, sources of support, legal options, and much more.

Harvey I. Pass, MD is Professor of Cardiothoracic Surgery and Surgery, Director of Surgical Research, and Division Chief for Thoracic Surgery and Thoracic Oncology for the NYU School of Medicine. Dr. Pass received his undergraduate education from Johns Hopkins University and graduated from Duke University Medical School.''He trained in Cardiothoracic Surgery at the Medical University of South Carolina in Charleston, SC.''He was a Senior staff fellow in the Thoracic Oncology Section at the National Cancer Institute/NIH in Bethesda, MD from 1983-1986 and became Head of Thoracic Oncology at NCI from 1986-1996. Before moving to New York, he was Professor of Surgery and Oncology for Wayne State University and the Karmanos Cancer Institute.'He is internationally recognized as an expert in the multidisciplinary management of lung cancer, mesothelioma, esophageal cancer, and the management of pulmonary metastases.''He is known for his development of novel clinical trials for the treatment of thoracic malignancies as well as building a strong translational component to his programs with benchwork investigations. ''Dr. Pass is supported by grants from the National Cancer and has co-authored over 300 original reports. He has edited three editions of Lung Cancer: Principles and Practice.''He is the Associate Editor for the Journal of Thoracic Oncology and the Surgical Editor for Clinical Lung Cancer. Dr. Pass has received the NIH Directors Award, the Presidents Award for Clinical Research at Karmanos Cancer Institute, the Wagner Medal from the International Mesothelioma Interest Group, and the Pioneer Award from the MesoFoundation.'He is presently a Board Member of the International Association for the Study of Lung Cancer, the International Mesothelioma Interest Group, The Addario Foundation, and the Lung Cancer Alliance. Dr. Pass has been recognized as an America’s Top Doctor and Best Cancer Doctor by Castle Connoly’s Guide for the last seven years. ''

Erscheinungsdatum
Verlagsort Sudbury
Sprache englisch
Gewicht 340 g
Themenwelt Medizin / Pharmazie Allgemeines / Lexika
Medizin / Pharmazie Medizinische Fachgebiete Onkologie
ISBN-10 1-284-24779-1 / 1284247791
ISBN-13 978-1-284-24779-4 / 9781284247794
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Hannes Leischner

Buch | Softcover (2023)
Urban & Fischer in Elsevier (Verlag)
27,00
Resilienz innovativ stärken : ein Praxishandbuch

von Christa Diegelmann; Margarete Isermann; Tanja Zimmermann

Buch | Softcover (2023)
Kohlhammer (Verlag)
36,00